Annual Working Capital
$19.46 M
-$21.32 M-52.28%
December 31, 2023
Summary
- As of February 26, 2025, MBRX annual working capital is $19.46 million, with the most recent change of -$21.32 million (-52.28%) on December 31, 2023.
- During the last 3 years, MBRX annual working capital has risen by +$5.18 million (+36.28%).
- MBRX annual working capital is now -71.75% below its all-time high of $68.88 million, reached on December 31, 2021.
Performance
MBRX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$6.01 M
-$1.97 M-24.70%
September 30, 2024
Summary
- As of February 26, 2025, MBRX quarterly working capital is $6.01 million, with the most recent change of -$1.97 million (-24.70%) on September 30, 2024.
- Over the past year, MBRX quarterly working capital has stayed the same.
- MBRX quarterly working capital is now -92.79% below its all-time high of $83.44 million, reached on March 31, 2021.
Performance
MBRX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
MBRX Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -52.3% | 0.0% |
| 3 y3 years | +36.3% | -79.1% |
| 5 y5 years | +375.1% | -79.1% |
MBRX Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -71.8% | at low | -91.3% | at low |
| 5 y | 5-year | -71.8% | +96.3% | -92.8% | at low |
| alltime | all time | -71.8% | +2712.9% | -92.8% | +973.6% |
Moleculin Biotech Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $6.01 M(-24.7%) |
| Jun 2024 | - | $7.99 M(-41.1%) |
| Mar 2024 | - | $13.55 M(-30.4%) |
| Dec 2023 | $19.46 M(-52.3%) | $19.46 M(-18.0%) |
| Sep 2023 | - | $23.71 M(-17.7%) |
| Jun 2023 | - | $28.83 M(-15.9%) |
| Mar 2023 | - | $34.26 M(-16.0%) |
| Dec 2022 | $40.78 M(-40.8%) | $40.78 M(-13.5%) |
| Sep 2022 | - | $47.13 M(-15.0%) |
| Jun 2022 | - | $55.46 M(-11.2%) |
| Mar 2022 | - | $62.43 M(-9.4%) |
| Dec 2021 | $68.88 M(+382.4%) | $68.88 M(-6.2%) |
| Sep 2021 | - | $73.41 M(-6.5%) |
| Jun 2021 | - | $78.49 M(-5.9%) |
| Mar 2021 | - | $83.44 M(+484.4%) |
| Dec 2020 | $14.28 M | $14.28 M(+20.9%) |
| Sep 2020 | - | $11.81 M(-26.2%) |
| Jun 2020 | - | $16.01 M(+51.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $10.55 M(+6.4%) |
| Dec 2019 | $9.91 M(+142.0%) | $9.91 M(+32.8%) |
| Sep 2019 | - | $7.47 M(-29.6%) |
| Jun 2019 | - | $10.61 M(+234.0%) |
| Mar 2019 | - | $3.18 M(-22.4%) |
| Dec 2018 | $4.10 M(-32.7%) | $4.10 M(-34.3%) |
| Sep 2018 | - | $6.23 M(-29.0%) |
| Jun 2018 | - | $8.78 M(-26.6%) |
| Mar 2018 | - | $11.95 M(+96.3%) |
| Dec 2017 | $6.09 M(+57.0%) | $6.09 M(-20.2%) |
| Sep 2017 | - | $7.63 M(-7.5%) |
| Jun 2017 | - | $8.25 M(+18.8%) |
| Mar 2017 | - | $6.95 M(+79.2%) |
| Dec 2016 | $3.88 M(-620.6%) | $3.88 M(-24.7%) |
| Sep 2016 | - | $5.15 M(-16.4%) |
| Jun 2016 | - | $6.16 M(-994.5%) |
| Mar 2016 | - | -$688.30 K |
| Dec 2015 | -$744.70 K | - |
FAQ
- What is Moleculin Biotech annual working capital?
- What is the all time high annual working capital for Moleculin Biotech?
- What is Moleculin Biotech annual working capital year-on-year change?
- What is Moleculin Biotech quarterly working capital?
- What is the all time high quarterly working capital for Moleculin Biotech?
- What is Moleculin Biotech quarterly working capital year-on-year change?
What is Moleculin Biotech annual working capital?
The current annual working capital of MBRX is $19.46 M
What is the all time high annual working capital for Moleculin Biotech?
Moleculin Biotech all-time high annual working capital is $68.88 M
What is Moleculin Biotech annual working capital year-on-year change?
Over the past year, MBRX annual working capital has changed by -$21.32 M (-52.28%)
What is Moleculin Biotech quarterly working capital?
The current quarterly working capital of MBRX is $6.01 M
What is the all time high quarterly working capital for Moleculin Biotech?
Moleculin Biotech all-time high quarterly working capital is $83.44 M
What is Moleculin Biotech quarterly working capital year-on-year change?
Over the past year, MBRX quarterly working capital has changed by $0.00 (0.00%)